|
Reference/year | Part of the plant | Extraction method | Chemical composition | | Biological activities |
|
Benovit et al. (2015) [6] | Leaves | Hydrodistillation/Clevenger | 1,8-Cineole (18.54%), sabinense (9.5%), guaiol (6.79%), and bicyclogermacrene (5.12%) | In vivo | Sedative/anesthetic |
Arze et al., (2013) [16] | Leaves | Hydrodistillation/Clevenger | Sabinene (30–35%), ß-pinene (8–10%), and ß-caryophyllene (∼8%) | — | — |
Bersan et al., (2014) [17] | Leaves | Hydrodistillation/Clevenger | E-Pinocamphone (16.07%), ß-pinene (12.01%), guaiol (8.53%), E-pinocarveol acetate (8.19%), and α-caryophyllene (7.19%) | In vitro | Antimicrobial |
Consolini et al. (2011) [18] | Leaves | Decoction | — | In vivo | Antispasmodic |
Freires et al. (2015) [19] | Leaves | Hydrodistillation/Clevenger | Guaiol (29.63%), trans-pinocarveol (13.16%), bulnesol (11.79%), and myrtenol (5.3 1%) | In vitro | Antimicrobial |
Galvez et al. (2020) [20] | Leaves | Hydrodistillation/Clevenger | β-Thujone (36.1 ± 0.1%), α-thujone (32.2 ± 0.2%), 1,8-cineol (10.7 ± 0.1%), and sabinene (6.2 ± 0.2%) | In vitro | Antifungal |
Garcia et al. (2003) [21] | Leaves | Hydrodistillation/Clevenger | Caryophyllene oxide (15.84%), cadinol (17.37%), chrysanthenyl acetate (5.61%), limonene oxide (5.29%), and ß-caryophyllene (4.77%) | In vivo | Virucidal—JUNV e HSV-1 |
Garcia et al. (2018) [22] | Leaves and fruits | Hydrodistillation/Clevenger | 1,8-Cineole (17.64%) and guaiol (10.33%) | In vivo | Antileishmanial activity |
Hister et al. (2009) [23] | Leaves | Hydrodistillation/Clevenger | — | In vitro | Inhibition of tumor cells growth |
Ricciardi et al. (2006) [9] | Leaves | Hydrodistillation/Clevenger | β –Caryophyllene (25.1%), germacrene D (10.1%), bicyclogermacrene (12.6%), and α-thujone (10.7%) | — | — |
Santos et al. (2015) [24] | Leaves | Hydrodistillation/Clevenger | 1,8-Cineole (13.7%), germacrene D (13.4%), ß-caryophyllene (12.7%), and ß-pinene (11.7%) | In vitro | Antibacterial and antifungal |
Soler (1986) [25] | Leaves | — | β-Pinene (8%) | — | — |
Souza and Wiest (2007) [11] | — | Decoction | — | In vitro | Bacteriostatic |
Souza et al. (2020) [13] | Leaves | Supercritical fluid with carbon dioxide | Guaiol (18.50%) and pinocamphone (11.40%) | In vivo | Anti-inflammatory |
Souza et al. (2020) [26] | Leaves | Supercritical fluid with carbon dioxide | Guaiol (18.50%) and pinocamphone (11.40%) | In vivo | Antinociceptive |
Trovati et al. (2009) [27] | Leaves | Hydrodistillation/Clevenger | Isopinocamphone (trans-3-pinanone; 25.4%), limonene (15.1%), and guaiol (12.7%) | — | — |
Vandresen et al. (2010) [28] | Leaves | Cold maceration/ethanol | α-bisabolol | In vitro | Antibacterial and Antiedematogenic effect |
Zeni et al. (2011) [14] | Leaves | Hydrodistillation/Clevenger | — | In vivo | Antidepressant-like effect |
Zeni et al. (2013) [29] | Leaves | Decoction | Ferulic acid (11.57–86.40 mg/100 g), trans-cinnamic acid (7.97–56.92 mg/100 g), and p-coumaric acid (0.00–16.06 mg/100) | In vivo and in vitro | Toxicity and antioxidant |
Zeni et al. (2013) [30] | Stems and leaves | Decoction | — | In vivo | Antidepressant-like effect |
Da Silva et al. (2006) [31] | Leaves | Cold maceration/ethanol | Guaiol, bisabolol, and spathulenol | — | — |
Santos et al. (2013) [32] | Leaves | Hydrodistillation/Clevenger | Transpinocarveyl acetate (17.6%), trans-pinocamphone (16.3%), and guaiol (11.5%) | In vitro | Antibacterial and antifungal |
|